Cargando…

YTHDF2 promotes temozolomide resistance in glioblastoma by activation of the Akt and NF‐κB signalling pathways via inhibiting EPHB3 and TNFAIP3

OBJECTIVES: Temozolomide (TMZ) resistance is a key factor that restricts the therapeutic effect of glioblastoma (GBM). YTH‐domain family member 2 (YTHDF2) is highly expressed in GBM tissues, while the mechanism of YTHDF2 in TMZ resistance in GBM remains not fully elucidated. METHODS: The YTHDF2 expr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Yu, Wang, Yan‐Lan, Qiu, Kai, Cao, Yi‐Qiang, Zhang, Feng‐Jiang, Zhao, Hai‐Biao, Liu, Xian‐Zhi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9082891/ https://www.ncbi.nlm.nih.gov/pubmed/35582627 http://dx.doi.org/10.1002/cti2.1393

Ejemplares similares

miR-125b controls apoptosis and temozolomide resistance by targeting TNFAIP3 and NKIRAS2 in glioblastomas
por: Haemmig, S, et al.
Publicado: (2014)

ADAR3 activates NF-κB signaling and promotes glioblastoma cell resistance to temozolomide
por: Raghava Kurup, Reshma, et al.
Publicado: (2022)

TNFAIP3 alleviates pain in lumbar disc herniation rats by inhibiting the NF-κB pathway
por: Xie, Zhaohui, et al.
Publicado: (2022)

A20 (TNFAIP3) Alleviates CVB3-Induced Myocarditis via Inhibiting NF-κB Signaling
por: Gui, Jun, et al.
Publicado: (2012)

CDK1 is up-regulated by temozolomide in an NF-κB dependent manner in glioblastoma
por: Voce, David J., et al.
Publicado: (2021)

MicroRNA-19b-3p regulates nasopharyngeal carcinoma radiosensitivity by targeting TNFAIP3/NF-κB axis
por: Huang, Teng, et al.
Publicado: (2016)

Melatonin antagonizes ovarian aging via YTHDF2-MAPK-NF-κB pathway
por: Zhu, Ruigong, et al.
Publicado: (2020)

Temozolomide in Combination With NF-κB Inhibitor Significantly Disrupts the Glioblastoma Multiforme Spheroid Formation
Publicado: (2020)

Transcription of Tnfaip3 Is Regulated by NF-κB and p38 via C/EBPβ in Activated Macrophages
por: Lai, Ting-Yu, et al.
Publicado: (2013)

Let-7 miRNAs Modulate the Activation of NF-κB by Targeting TNFAIP3 and Are Involved in the Pathogenesis of Lupus Nephritis
por: Liu, Jun, et al.
Publicado: (2015)

NF-κB inhibitor with Temozolomide results in significant apoptosis in glioblastoma via the NF-κB(p65) and actin cytoskeleton regulatory pathways
por: Avci, Naze G., et al.
Publicado: (2020)

Rh-relaxin-2 attenuates degranulation of mast cells by inhibiting NF-κB through PI3K-AKT/TNFAIP3 pathway in an experimental germinal matrix hemorrhage rat model
por: Li, Peng, et al.
Publicado: (2020)

Down-regulation of ABCE1 inhibits temozolomide resistance in glioma through the PI3K/Akt/NF-κB signaling pathway
por: Zhang, Peng, et al.
Publicado: (2018)

YTHDF1 Promotes Bladder Cancer Cell Proliferation via the METTL3/YTHDF1–RPN2–PI3K/AKT/mTOR Axis
por: Zhu, Junlong, et al.
Publicado: (2023)

Stimulation of EphB2 attenuates tau phosphorylation through PI3K/Akt-mediated inactivation of glycogen synthase kinase-3β
por: Jiang, Jun, et al.
Publicado: (2015)

Inhibition of NF-κB by Dehydroxymethylepoxyquinomicin Suppresses Invasion and Synergistically Potentiates Temozolomide and γ-Radiation Cytotoxicity in Glioblastoma Cells
por: Brassesco, M. S., et al.
Publicado: (2013)

A20/TNFAIP3 Discriminates Tumor Necrosis Factor (TNF)-Induced NF-κB from JNK Pathway Activation in Hepatocytes
por: Pinna, Federico, et al.
Publicado: (2017)

Synergistic activation of NF-κB by TNFAIP3 (A20) reduction and UBE2L3 (UBCH7) augment that synergistically elevate lupus risk
por: Kim, Taehyeung, et al.
Publicado: (2020)

BKM120 sensitizes C6 glioma cells to temozolomide via suppression of the PI3K/Akt/NF-κB/MGMT signaling pathway
por: Li, Mao, et al.
Publicado: (2017)

An Autoimmune Disease-Associated Risk Variant in the TNFAIP3 Gene Plays a Protective Role in Brucellosis That Is Mediated by the NF-κB Signaling Pathway
por: Lou, Lixin, et al.
Publicado: (2018)

Low Expression of EphB2, EphB3, and EphB4 in Bladder Cancer: Novel Potential Indicators of Muscular Invasion
por: Lee, Tae Ho, et al.
Publicado: (2021)

MicroRNA-101 reverses temozolomide resistance by inhibition of GSK3β in glioblastoma
por: Tian, Tian, et al.
Publicado: (2016)

TNFAIP3 is anti-inflammatory in the retinal vasculature
por: Liu, Li, et al.
Publicado: (2022)

EGFRvIII Promotes the Proneural–Mesenchymal Transition of Glioblastoma Multiforme and Reduces Its Sensitivity to Temozolomide by Regulating the NF-κB/ALDH1A3 Axis
por: Shi, Zhong-Fang, et al.
Publicado: (2023)

NF-κB is activated in response to temozolomide in an AKT-dependent manner and confers protection against the growth suppressive effect of the drug
por: Caporali, Simona, et al.
Publicado: (2012)

Blockage of EGFR/AKT and mevalonate pathways synergize the antitumor effect of temozolomide by reprogramming energy metabolism in glioblastoma
por: Cui, Xiaoteng, et al.
Publicado: (2023)

NF-κB Signalling in Glioblastoma
por: Soubannier, Vincent, et al.
Publicado: (2017)

HOXD‐AS2‐STAT3 feedback loop attenuates sensitivity to temozolomide in glioblastoma
por: Zhang, Zuo‐Xin, et al.
Publicado: (2023)

A Model of iPSC-Derived Macrophages with TNFAIP3 Overexpression Reveals the Peculiarities of TNFAIP3 Protein Expression and Function in Human Macrophages
por: Sheveleva, Olga, et al.
Publicado: (2023)

Temozolomide resistance in glioblastoma multiforme
por: Lee, Sang Y.
Publicado: (2016)

YTHDF2 Regulates Macrophage Polarization through NF-κB and MAPK Signaling Pathway Inhibition or p53 Degradation
por: Cai, Luhui, et al.
Publicado: (2022)

Glutathione S-Transferase M3 Is Associated with Glycolysis in Intrinsic Temozolomide-Resistant Glioblastoma Multiforme Cells
por: Cheng, Shu-Yu, et al.
Publicado: (2021)

YTHDF2 facilitates UBXN1 mRNA decay by recognizing METTL3-mediated m(6)A modification to activate NF-κB and promote the malignant progression of glioma
por: Chai, Rui-Chao, et al.
Publicado: (2021)

Involvement of Akt/NF-κB pathway in antitumor effects of parthenolide on glioblastoma cells in vitro and in vivo
por: Nakabayashi, Hiromichi, et al.
Publicado: (2012)

Resveratrol Inhibits the Invasion of Glioblastoma-Initiating Cells via Down-Regulation of the PI3K/Akt/NF-κB Signaling Pathway
por: Jiao, Yuming, et al.
Publicado: (2015)

HMBA Enhances Prostratin-Induced Activation of Latent HIV-1 via Suppressing the Expression of Negative Feedback Regulator A20/TNFAIP3 in NF-κB Signaling
por: Chen, Duchu, et al.
Publicado: (2016)

Decrease of miR-19b-3p in Brain Microvascular Endothelial Cells Attenuates Meningitic Escherichia coli-Induced Neuroinflammation via TNFAIP3-Mediated NF-κB Inhibition
por: Amjad, Nouman, et al.
Publicado: (2019)

NF-κB, Mesenchymal Differentiation and Glioblastoma
por: Yamini, Bakhtiar
Publicado: (2018)

Rare variation at the TNFAIP3 locus and susceptibility to rheumatoid arthritis
por: Bowes, John, et al.
Publicado: (2010)

TNFAIP3 Facilitates Degradation of Microbial Antigen SEB in Enterocytes
por: Chen, Chi, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_m5spuu6464s0rihecgdbmp5c0s